Interesting reading and well informed. CYP 28 day readout just 3...

Interesting reading and well informed. CYP 28 day readout just 3 weeks away and the Fuji option over the deals with CYP as they stand now, will expire 90 days later. Fuji owns a strategic parcel which, with a little top up allows them to thwart any unwelcome takeover should they need to protect their interests in the Cymerus technology. CYP will continue increasing their leverage as they develop more and more cooperation and report results as they have been doing. IMO, Fuji is playing for big upside in a big game and, I think, will be on board sooner, rather than later. If the 28 day read out for cohort B is equal or better than the results of cohort A and confirm the safety of the product, the reduced risk factor will underwrite the value of the deals for Fuji and become very compelling.